@misc{indiciae64f21a43bc02,
  title = {Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trial.},
  author = {Takashi Yamanaka and Joohyuk Sohn and Kazuki Sudo and Hirofumi Mukai and Naohito Yamamoto and Chi-Feng Chung and Yen-Shen Lu and Kyung-Hun Lee and Soo-Chin Lee and Tsutomu Iwasa and Hiroji Iwata and Kenichi Watanabe and Kyung Hae Jung and Yuko Tanabe and Seok Yun Kang and Hiroyuki Yasojima and Kenjiro Aogi and Eriko Tokunaga and Sung Hoon Sim and Yoon Sim Yap and Koji Matsumoto and Ling-Ming Tseng and Yoshiko Umeyama and Emi Noguchi and Tomomi Hata and Aya Kuchiba and Taro Shibata and Kenichi Nakamura and Yasuhiro Fujiwara and Kenji Tamura and Kan Yonemori},
  year = {2026},
  doi = {10.1007/s12282-026-01865-0},
  url = {https://pubmed.ncbi.nlm.nih.gov/42340618/},
  note = {Source identifier: 42340618}
}